Abstract
We hope to assess the different processing methodologies or the effectiveness of the devices or systems applied in this nonparametric statistical test by observing the failure behavior of the recorded survival data. The proposed second-order approach of new better than used (NBU 2) will be employed, which requires that the test data behaves either like NBU 2 property or exponentially. If the survival data is NBU 2, the proposed treatment method is likely to be beneficial. If the data are exponential, on the other hand, the recommended treatment method has no positive or negative influence on patients, as shown in the application section. To establish the validity of the test, we calculated the power of the proposed test and efficiency on both complete and censored data, compared the results to those of existing tests, and then applied the test to a range of real-world data.